North America Patient Monitoring Devices Market Insights (2025-2035)
The North America Patient Monitoring Devices Market is witnessing robust growth, propelled by advances in remote patient monitoring (RPM), an aging population, increasing prevalence of chronic diseases, and the integration of AI and IoT technologies. The market encompasses a diverse portfolio, including cardiac monitoring, respiratory, hemodynamic, neuromonitoring, multi-parameter, and wearable devices. Hospitals, home healthcare, and specialty clinics are the primary distribution channels, with substantial adoption of wired, wireless, cloud-based, and AI-enabled patient monitoring systems. Market leaders such as Medtronic, GE Healthcare, and Philips Healthcare are continuously expanding product portfolios and investing in next-generation monitoring solutions. The projected market trajectory indicates strong CAGR through 2035, with the US remaining the dominant regional force. Segmental growth is primarily seen in cardiac and remote patient monitoring devices, further accelerated by telehealth trends and digital transformation within healthcare delivery.
Latest Market Dynamics
Key Drivers
Rising prevalence of chronic diseases including cardiovascular and respiratory conditions, prompting higher demand for continuous patient monitoring. For instance, Medtronic introduced their latest AI-powered cardiac monitoring solutions to address increased heart disease detection in the US.
Accelerated adoption of remote patient monitoring and telemedicine post-pandemic, with technology companies like Philips launching integrated remote monitoring platforms that connect patients and healthcare providers seamlessly.
Key Trends
Expansion of wearable and IoT-enabled patient monitoring devices, as shown by Abbott’s 2024 launch of next-gen wearable biosensors in partnership with major health systems.
Increasing integration of AI and cloud-based analytics into patient monitoring solutions, with GE Healthcare advancing AI-supported clinical decision-making tools through strategic partnerships in 2024.
Key Opportunities
Expansion in home healthcare monitoring, providing a cost-effective alternative to hospital stays, with Masimo unveiling home-based monitoring kits aimed at chronic illness management.
Development of personalized, predictive analytics solutions driven by AI, where Siemens Healthineers introduced smart adaptive monitoring solutions tailored to individual patient profiles.
Key Challenges
Data privacy and cybersecurity concerns in cloud-based and connected patient monitoring ecosystems, highlighted by recent cybersecurity investments by Drägerwerk and other vendors.
Complex regulatory landscape and approval timelines for next-gen monitoring devices, impacting time-to-market for innovative solutions as seen with Mindray navigating updated FDA and Health Canada requirements.
Key Restraints
High cost of advanced patient monitoring devices restricting adoption among smaller healthcare settings, with Smiths Medical focusing on cost-reduction through scalable modular technology in 2024.
Market fragmentation and interoperability issues among devices from different suppliers, prompting Stryker and Schiller AG to enhance cross-device compatibility standards.
North America Patient Monitoring Devices Market Share by Type, 2025
Cardiac Monitoring Devices hold the largest share of the patient monitoring devices market in North America for 2025, reflecting steady demand driven by the prevalence of cardiovascular disease and hospital adoption of advanced monitoring technologies. Respiratory and remote patient monitoring devices are also key contributors, benefitting from increased telehealth expansion and a shift towards outpatient and home-based care. Neuromonitoring and multi-parameter devices are seeing steady adoption due to rising neurological and critical care incidences. The chart below demonstrates the distribution of market share by major device types, highlighting the areas of most significant growth and focus in the region.
North America Patient Monitoring Devices Market Share by Application, 2025
Cardiology applications dominate the North America Patient Monitoring Devices Market in 2025, accounting for the largest portion due to the region’s high incidence of cardiovascular conditions and standardized hospital protocols. Remote patient monitoring is quickly gaining ground, spurred by trends in telemedicine and aging demographics. Neurology and respiratory monitoring hold significant positions thanks to increased awareness of neurological and pulmonary disorders. The pie chart below represents the proportional split across application segments, reflecting evolving patient monitoring preferences and technological adoption patterns.
North America Patient Monitoring Devices Market Revenue (USD Million), 2020-2035
Market revenue for Patient Monitoring Devices in North America shows consistent and substantial growth from 2020 through 2035. Due to growing adoption of digital health infrastructure, the use of AI and IoT in medical devices, and investment by both large hospital networks and smaller clinics, the sector is set to reach unprecedented levels. The chart below illustrates a steady upward trajectory, projecting the market to reach $17,600 Million by 2035, reflecting a strong CAGR and underscoring technology’s role in reshaping patient care models.
North America Patient Monitoring Devices Market YOY Growth (%), 2020-2035
Year-over-year growth analysis reveals peak momentum in the early 2020s due to accelerated adoption of remote monitoring solutions during and after the COVID-19 pandemic. Growth rates are projected to stabilize yet remain strong through 2035 as healthcare systems continue to integrate digital monitoring and predictive analytics. The chart demonstrates a peak YOY growth of over 9% in 2025–2030, gradually tapering as the market matures and achieves broader technology penetration.
North America Patient Monitoring Devices Market Share by Region, 2025
The United States holds a commanding lead within North America, responsible for the majority of device adoption due to advanced healthcare infrastructure, higher healthcare spending, and greater technological uptake. Canada follows, supported by nationwide health reforms and digital health initiatives, while Mexico’s share reflects emerging market trends and growing epidemiological needs. The regional split affirms the significant imbalance weighted toward the US, though all regions contribute to overall market vibrancy.
North America Patient Monitoring Devices Market Players Share (%), 2025
Market participation is led by legacy companies with established distribution and research pipelines. Medtronic, GE Healthcare, and Philips collectively represent almost half of the regional market share, reflecting their continued innovation, strategic partnerships, and diversified portfolios. Upcoming players such as Masimo and Mindray are making notable advances, challenging incumbent positions and diversifying the ecosystem. Competitive dynamics remain intense with ongoing investment in R&D and digital health partnerships.
North America Patient Monitoring Devices Market Buyers Share (%), 2025
Healthcare providers, including hospital networks and specialty clinics, make up the largest share of buyers, accounting for over half the demand in 2025. Home healthcare segment is expanding rapidly due to the aging population and preference for out-of-hospital monitoring. Online and retail channels are emerging as important procurement routes in a post-pandemic landscape. The data highlights how evolving care models are shifting procurement patterns in the patient monitoring sector.
Study Coverage
Metrics
Details
Years
2020-2035
Base Year
2025
Market Size
10300
Regions
North America
Segments
By Type, By Application, By Distribution Channels, By Technology, By Organization Size
June 2024: Medtronic announced FDA approval for its next-generation AI-powered cardiac monitoring platform designed for real-time hospital and remote patient surveillance.
June 2024: Philips launched a comprehensive cloud-based remote patient monitoring suite, partnering with leading US hospitals for advanced telehealth solutions.
July 2024: Abbott partnered with the Mayo Clinic to pilot new wearable biosensors for chronic disease monitoring, expanding its digital health ecosystem.
July 2024: Masimo introduced an all-in-one home monitoring kit targeting chronic respiratory disease management, enabling seamless integration with virtual care platforms.
August 2024: Siemens Healthineers revealed its personalized, adaptive AI patient monitoring solution aimed at optimizing early intervention and outcomes in intensive care.
Frequently Asked Questions
About the Author
Sophia
Lead Industry Analyst
Sophia is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Sophia brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Sophia has helped organizations translate data into actionable growth strategies.
